Folgen
Clara Natoli
Clara Natoli
Department of Medical, Oral and Biotechnological Sciences and CeSI-MeT University G. D'Annunzio
Bestätigte E-Mail-Adresse bei unich.it
Titel
Zitiert von
Zitiert von
Jahr
Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response?
GA Rabinovich, LG Baum, N Tinari, R Paganelli, C Natoli, FT Liu, ...
Trends in immunology 23 (6), 313-320, 2002
7492002
Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases.
P Patrignani, MR Panara, A Greco, O Fusco, C Natoli, S Iacobelli, ...
Journal of Pharmacology and Experimental Therapeutics 271 (3), 1705-1712, 1994
6521994
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally …
D Miles, J Gligorov, F André, D Cameron, A Schneeweiss, C Barrios, B Xu, ...
Annals of Oncology 32 (8), 994-1004, 2021
5352021
Concentrations of galectin-3 in the sera of normal controls and cancer patients
I Iurisci, N Tinari, C Natoli, D Angelucci, E Cianchetti, S Iacobelli
Clinical cancer research 6 (4), 1389-1393, 2000
4372000
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable
A Cortellini, M Bersanelli, S Buti, K Cannita, D Santini, F Perrone, R Giusti, ...
Journal for immunotherapy of cancer 7, 1-11, 2019
3732019
Galectin‐3 overexpression protects from apoptosis by improving cell adhesion properties
P Matarrese, O Fusco, N Tinari, C Natoli, FT Liu, ML Semeraro, W Malorni, ...
International journal of cancer 85 (4), 545-554, 2000
3492000
The secreted tumor-associated antigen 90K is a potent immune stimulator
A Ullrich, I Sures, M D'Egidio, B Jallal, TJ Powell, R Herbst, A Dreps, ...
Journal of Biological Chemistry 269 (28), 18401-18407, 1994
2451994
90K (Mac-2 BP) and galectins in tumor progression and metastasis
A Grassadonia, N Tinari, I Iurisci, E Piccolo, A Cumashi, P Innominato, ...
Glycoconjugate journal 19, 551-556, 2002
2232002
Galectin‐3 overexpression protects from cell damage and death by influencing mitochondrial homeostasis
P Matarrese, N Tinari, ML Semeraro, C Natoli, S Iacobelli, W Malorni
FEBS letters 473 (3), 311-315, 2000
2002000
Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in …
V Graziano, A Grassadonia, L Iezzi, P Vici, L Pizzuti, M Barba, A Quinzii, ...
The Breast 44, 33-38, 2019
1792019
PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis
F Passiglia, G Bronte, V Bazan, C Natoli, S Rizzo, A Galvano, A Listì, ...
Oncotarget 7 (15), 19738, 2016
1752016
Triple positive breast cancer: a distinct subtype?
P Vici, L Pizzuti, C Natoli, T Gamucci, L Di Lauro, M Barba, D Sergi, ...
Cancer treatment reviews 41 (2), 69-76, 2015
1572015
Prognostic value of a novel circulating serum 90K antigen in breast cancer
S Iacobelli, P Sismondi, M Giai, M d'Egidio, N Tinari, C Amatetti, ...
British journal of cancer 69 (1), 172-176, 1994
1431994
Gynaecomastia with cimetidine
GF Delle Fave, G Tamburrano, L De Magistris, C Natoli, ML Santoro, ...
Lancet 1 (8025), 1319, 1977
1321977
Immunotherapy in HER2-positive breast cancer: state of the art and future perspectives
E Krasniqi, G Barchiesi, L Pizzuti, M Mazzotta, A Venuti, M Maugeri-Saccà, ...
Journal of hematology & oncology 12, 1-26, 2019
1242019
Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies
P Vici, L Pizzuti, L Mariani, G Zampa, D Santini, L Di Lauro, T Gamucci, ...
Expert review of vaccines 15 (10), 1327-1336, 2016
1102016
Elevated serum levels of 90K/MAC-2 BP predict unresponsiveness to α-interferon therapy in chronic HCV hepatitis patients
M Artini, C Natoli, N Tinari, A Costanzo, R Marinelli, C Balsano, P Porcari, ...
Journal of hepatology 25 (2), 212-217, 1996
1071996
Molecular mechanisms of endocrine resistance and their implication in the therapy of breast cancer
M Zilli, A Grassadonia, N Tinari, A Di Giacobbe, S Gildetti, J Giampietro, ...
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1795 (1), 62-81, 2009
1052009
Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/Programmed cell death …
A Cortellini, M Bersanelli, D Santini, S Buti, M Tiseo, K Cannita, F Perrone, ...
European Journal of Cancer 128, 17-26, 2020
1032020
Effect of gender on the outcome of patients receiving immune checkpoint inhibitors for advanced cancer: a systematic review and meta-analysis of phase III randomized clinical …
A Grassadonia, I Sperduti, P Vici, L Iezzi, D Brocco, T Gamucci, L Pizzuti, ...
Journal of Clinical Medicine 7 (12), 542, 2018
1022018
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20